BIIB vs TECH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BIIB Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biogen Inc. Common Stock (BIIB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TECH counters with relative strength in Valuation. Fundamentally, BIIB trades at 15.6x Forward P/E with 23.5% operating margin (+10.6% YoY revenue) versus TECH at 42.8x Forward P/E and 21.7% operating margin (+4.6% YoY). In options structure, BIIB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against TECH sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BIIB | TECH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $37.0B | $11.4B | Larger Scale | BIIB |
| Trailing P/E Ratio Valuation | 109.9x | 66.8x | Lower Multiple | TECH |
| Forward P/E Ratio Valuation | 15.6x | 42.8x | Lower Multiple | BIIB |
| Revenue Growth (YoY) Growth | +10.6% | +4.6% | Higher Growth | BIIB |
| Operating Margin (TTM) Profitability | 23.5% | 21.7% | Higher Margin | BIIB |
| Net Profit Margin Profitability | 3.4% | 14.0% | Higher Margin | TECH |
| Return on Equity (ROE) Capital Efficiency | 1.9% | 8.3% | Higher ROE | TECH |
| 52-Week Range Position Momentum | 92% ($160โ$261) | 100% ($43โ$73) | Stronger Trend | TECH |
| Beta / 30D Volatility Risk Regime | 0.27ฮฒ ยท 36% Vol | 0.37ฮฒ ยท 1% Vol | Lower Realized Risk | TECH |
| Unified Institutional Score Composite Signal | 50.2 / 100 (HOLD) | 52.4 / 100 (HOLD) | Higher Composite | TECH |